Inhibiting store-operated calcium entry attenuates white matter secondary degeneration following SCI

Neurobiol Dis. 2020 Mar:136:104718. doi: 10.1016/j.nbd.2019.104718. Epub 2019 Dec 14.

Abstract

Axonal degeneration plays a key role in the pathogenesis of numerous neurological disorders including spinal cord injury. After the irreversible destruction of the white matter elements during the primary (mechanical) injury, spared axons and their supporting glial cells begin to breakdown causing an expansion of the lesion site. Here we mechanistically link external sources of calcium entry through axoplasmic reticulum calcium store depletion that contributes to secondary axonal degeneration through a process called store-operated calcium entry. There is increasing evidence suggesting that store-operated calcium entry impairment is responsible for numerous disorders. Nevertheless, its role following spinal cord injury remains poorly understood. We hypothesize that store-operated calcium entry mediates secondary white matter degeneration after spinal cord injury. We used our previously published model of laser-induced spinal cord injury to focally transect mid cervical dorsal column axons from live 6-8-week-old heterozygous CNPaseGFP/+: Thy1YFP+ double transgenic murine spinal cord preparations (five treated, eight controls) and documented the dynamic changes in axons over time using two-photon excitation microscopy. We report that 1 hour delayed treatment with YM-58483, a potent inhibitor of store-operated calcium entry, significantly decreased intra-axonal calcium accumulation, axonal dieback both proximal and distal to the lesion site, reduced secondary axonal "bystander" damage acutely after injury, and promoted greater oligodendrocyte survival compared to controls. We also targeted store-operated calcium entry following a clinically relevant contusion spinal cord injury model in vivo. Adult, 6-8-week-old Advillin-Cre: Ai9 mice were subjected to a mild 30 kdyn contusion and imaged to observe secondary axonal degeneration in live animals. We found that delayed treatment with YM-58483 increased axonal survival and reduced axonal spheroid formation compared to controls (n = 5 mice per group). These findings suggest that blocking store-operated calcium entry acutely is neuroprotective and introduces a novel target to prevent pathological calcium entry following spinal cord injury using a clinically relevant model.

Keywords: Axonal retraction; Calcium; Intravital microscopy; Neuroprotection; Oligodendrocyte; Spinal cord injury; Store-operated calcium entry; Two-photon excitation microscopy; White matter.

MeSH terms

  • Anilides / pharmacology*
  • Anilides / therapeutic use
  • Animals
  • Calcium-Binding Proteins / antagonists & inhibitors*
  • Calcium-Binding Proteins / metabolism*
  • Female
  • Male
  • Membrane Proteins / antagonists & inhibitors*
  • Membrane Proteins / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / metabolism*
  • Nerve Degeneration / pathology
  • Organ Culture Techniques
  • Spinal Cord / drug effects
  • Spinal Cord / metabolism
  • Spinal Cord / pathology
  • Spinal Cord Injuries / drug therapy
  • Spinal Cord Injuries / metabolism*
  • Spinal Cord Injuries / pathology
  • Thiadiazoles / pharmacology*
  • Thiadiazoles / therapeutic use
  • White Matter / drug effects
  • White Matter / metabolism*
  • White Matter / pathology

Substances

  • 4-methyl-4'-(3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl)-1,2,3-thiadiazole-5-carboxanilide
  • Anilides
  • Calcium-Binding Proteins
  • Membrane Proteins
  • Saraf protein, rat
  • Thiadiazoles